RUBICON logo

Rubicon Research Limited

RUBICON·NSE·
1,823.00 +3.40 (+0.19%)
Market Cap29997.69 Cr
PE Ratio121.94
Volume2,39,796
Day High - Low1875.00 - 1795.50
52W High-Low1899.00 - 570.75
DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
27.00%
Strong
P/E
121.94x
Expensive
Debt / Equity
0.20
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day1796
1875
52W570.75
1899
DocStoX take

Supported by growth (8.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 8.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.7
/10
Fair
Quality
Solid
ROE 27.0%
Valuation
Expensive
P/E 121.9×
Growth
Strong
Revenue +41.0% 5Y CAGR
Risk
Moderate
D/E 0.20
Momentum
Strong
94% of 52-week range

At a glance

Market Cap
₹29,998 Cr
52W High / Low
₹1899 / ₹571
Dividend Yield
0.08%
Promoter Holding
59.76%
EPS (TTM)
₹14.95
Book Value
₹78.10

Key highlights

  • Profit compounding 51% a year
  • Revenue compounding 41% a year
  • Low leverage — D/E 0.20
  • Loss-making in some of the last 5 years
  • Valuation is weak (0.0/10)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

RUBICON RESEARCH LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.